Establishing a market position through high-value-added products and new brands

「In Japan, supplements such as Rohto V5, skincare products including Hada Labo, Care Cera and GYUTTO, eye drops for younger users and high-priced eye drops performed well, resulting in higher revenue.」

「As a major achievement for the consolidated fiscal year, under the flagship V Rohto Premium brand, we launched V Rohto Dry Guard Premium containing 1% chondroitin, as well as Alguard Epinastine Eye Drops under the Alguard brand, containing epinastine hydrochloride.」

「Lip creams with strong sales of new products, Hada Labo, the Rohto V5 supplement and GYUTTO, a hair mask launched in the previous fiscal year, performed well. Under this agreement, OBAGI permanently transferred to us all licenses and distribution rights for OBAGI-branded products across all sales channels in Japan, and we will acquire the related OBAGI trademarks in Japan.」

「Lip balms, supported by the strong performance of new products, the “ロートＶ５” supplement, “メラノＣＣ,” supported by the strong performance of its enzyme facial wash, “肌ラボ,” sunscreens and higher-priced eye drops continued to perform well.」

「As a major achievement for the consolidated fiscal year, we launched Rohto Lycee Glow, an eye drop that can reduce makeup smudging for women through an “ultra-small drop” delivered by a uniquely developed new container.」

「“メラノＣＣ,” supported by the strong performance of its enzyme facial wash, “肌ラボ” and the “ロートＶ５” supplement continued to perform well. Lip balms, whose sales had stagnated because of mask-wearing habits, also began to recover.」

「“メラノＣＣ,” supported by the strong performance of its enzyme facial wash, “肌ラボ” and the “ロートＶ５” supplement continued to perform well. Lip balms, whose sales had stagnated because of mask-wearing habits, also began to recover.」

「“メラノＣＣ,” supported by the strong performance of its enzyme facial wash, “肌ラボ” and the “ロートＶ５” supplement continued to perform well. Lip balms, whose sales had declined because of mask-wearing habits, also recovered to exceed pre-pandemic levels.」

「Melano CC Deep Clear Enzyme Facial Wash has been rolled out nationwide and has been very well received, including winning awards from various media outlets. We also launched Yakuyō Lip Repair One, a new brand dedicated to caring for lips prone to irritation.」

「“メラノＣＣ,” supported by the strong performance of its newly launched enzyme facial wash, and “スキンアクア,” which added new functionality to its sunscreen products, continued to perform well, as did “肌ラボ,” “オバジ” and “ロートＶ５粒.”」

「Skin Aqua, which added new functionality to its sunscreen, continued to perform well and contributed to higher revenue. Hada Labo, Obagi, Melano CC and Rohto V5 tablets also continued to perform well. Lip creams, whose sales had stagnated because of mask-wearing habits, began to recover, and the COVID-19 (SARS-CoV-2) rapid antigen test kit also contributed to higher revenue.」

「Demand for eye drops increased as more people experienced eye strain after spending more time using digital devices during the COVID-19 pandemic, and higher-priced eye drops generated higher sales. In addition, “メラノＣＣ,” “肌ラボ,” “デオコ” and “ロートＶ５粒” continued to perform well. Rapid antigen test kits for the novel coronavirus (SARS-CoV-２) also contributed to higher sales.」

「Despite the declaration of a state of emergency, sales of sunscreens, contact lenses and contact lens solutions increased, while Melano CC, Deoco and Rohto V5 tablets continued to perform well.」

「In addition, “ロートＶ５粒” and the Kampo and herbal medicine brand “和漢箋” performed steadily.」

「We launched V Rohto Contact Premium, a high-performance ophthalmic drug for contact lens users containing six active ingredients, including vitamin A, to address a range of eye concerns.」

「Meanwhile, Melano CC and Deoco continued to perform well, while Wakan Sen and Rohto V5 tablets also posted higher revenue.」

「Meanwhile, high-value-added eye drops and Deoco performed well.」

「Meanwhile, the serums Obagi C25 Serum Neo and Deoco performed well.」

「As a major achievement for the consolidated fiscal year, we launched Rohto Alguard Clinical Shot, a high-performance ophthalmic drug backed by clinical trials for severe eye itching, redness and foreign-body sensation caused by pollen and other factors. It is the first product in Japan to combine tranilast, an antiallergic agent, and pranoprofen, an anti-inflammatory agent.」

「Core eye-care products, including high-value-added products such as the V Rohto Premium series of high-performance ophthalmic drugs and contact lenses, performed steadily, while shipments of the new pollen-related product Rohto Alguard Clinical Shot also progressed smoothly.」

「Core eye-care products remained at roughly the same level as the previous year, despite steady sales of high-value-added products such as the V Rohto Premium series of high-performance ophthalmic drugs and contact lenses, due in part to a decline following the previous year’s collaboration between the Rohto Lycee series and Sailor Moon. Skincare products performed well, supported by the Obagi C25 Serum Neo, a serum providing comprehensive care from pores to skin firmness, and Deoco, which had attracted attention on social media, while pent-up demand ahead of the consumption tax increase also contributed to higher revenue.」

「As a result, net sales were ¥4,191 million, up 3.1% year on year. In Japan, although inbound demand has slowed, high-value-added products performed well, and seasonal products such as sunscreens and antiperspirants also progressed steadily.」

「New products including Regro, which contains minoxidil at the highest concentration in Japan and is indicated for hair growth, hair regrowth and prevention of hair-loss progression in male-pattern baldness, and Deoco, which addresses the changes in the body odor of adult women with age, contributed to higher revenue.」

「In addition to strong performance by high-performance products such as V Rohto Active Premium and Rohto Shinryokusu, the Rohto Lycee series, produced in collaboration with Sailor Moon, also performed steadily. Contact lenses also contributed to higher revenue, supported by strong sales of the new 1DAY Fresh View.」

「In Japan, high-value-added products performed well, while new products such as the sunscreen Skin Aqua Tone Up UV Essence also progressed steadily.」

「Core eye-care products, including the high-performance ophthalmic drug V Rohto Active Premium, performed steadily. In skincare, high-value-added products such as Hada Labo Gokujyun Premium and Obagi C Enzyme Facial Cleanser performed well, while new products including the highly moisturizing Mentholatum Melty Cream Lip and the soothingly scented itch treatment Mentholatum AD Botanical also contributed to higher revenue.」

「In Japan, high-value-added products including V Rohto Premium and Hada Labo Shirojun Premium performed well, while inbound demand also contributed.」

「In Japan, new products including Hada Labo Shirojun Premium and the sunscreen Skin Aqua performed well, and inbound demand also contributed.」

「As a major achievement for the consolidated fiscal year, we developed V Rohto Premium, a high-performance ophthalmic drug containing 12 active ingredients, the largest number in Japan, for people seriously troubled by the cumulative eye fatigue of modern life, in which muscles, tears and inflammation are jointly involved.」

「Core eye-care products performed well, supported by the new V Rohto Premium, while contact-lens-related products also remained solid. In skincare, sales of the Hada Labo series declined amid intensifying competition, but autumn and winter skincare products and the men’s deodorant brand De Ou remained solid, and sales driven by inbound demand, including Melano CC Medicated Intensive Spot Care Essence, were strong. In oral and food products, the new Tsurares series from the Kampo brand Wakan Sen, designed to address women’s concerns, contributed to sales after its launch.」

「Meanwhile, the men’s deodorant brand De Ou continued to perform well, while sales driven by inbound demand, including Melano CC Medicated Intensive Spot Care Essence, also remained strong.」

「The men’s deodorant brand De Ou, 50 no Megumi, which has added a color treatment that is gentle on the skin yet provides thorough coverage, and SUGAO, which has added Chiffon Feel Powder, among others, have performed well.」

「At the same time, we will work to establish a firm position in the market by developing high-value-added products that address new needs and cultivating new brands.」